Facial Injectable Market Size, Share & Trends Analysis Report By Product (Collagen & PMMA Microspheres, Botulinum Toxin Type A), By End-use, By Application, By Region, And Segment Forecasts, 2023 - 2030

Facial Injectable Market Size, Share & Trends Analysis Report By Product (Collagen & PMMA Microspheres, Botulinum Toxin Type A), By End-use, By Application, By Region, And Segment Forecasts, 2023 - 2030

Facial Injectable Market Growth & Trends

The global facial injectable market size is expected to reach USD 27.6 billion by 2030, expanding at 10.3% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc.The facial injectable is a substance that is used to reduce wrinkles and restore volume & fullness in the face. It is injected beneath the facial skin surface. Some commonly used facial injectables include hyaluronic acid, botulinum toxin type A, and polymer fillers.

Growing focus on physical appearance, especially in developing countries is one of the key factors expected to drive the market. In addition, a shift in consumer preference towards minimally invasive procedures is also expected to support market growth. According to the American Society of Plastic Surgeons (ASPS), in 2020, botulinum toxin A and soft tissue fillers were among the top 5 minimally invasive procedures carried out in the U.S. Thus, facial injectable holds high growth prospects in the years to come.

Asia Pacific region is expected to become a high-revenue generator in the global market. The region is backed by countries such as India, where a growing focus on physical appearance is expected to create a lucrative opportunity in the market. Companies such as Allergan are also expanding their presence in the country owing to the rise in the middle-class population backed by increasing disposable income.

The onset of the pandemic led to non-surgical and cosmetic surgeries being put on hold in the first and second quarters of 2020. However, the later months witnessed high demand for aesthetic consultations and procedures as patients were willing to undergo cosmetic treatments now more than ever due to high disposable income. Furthermore, new niche drivers such as a desire to look appealing on online video platforms and professional meetings also continue to drive growth.

Facial Injectable Market Report Highlights

• The botulinum toxin type A segment is projected to dominate the market throughout the forecast period. It is one of the most popular minimally invasive procedures
• The facial line correction segment is projected to grow rapidly over the forecast period owing to the rise in the use of facial injectables for aesthetic procedures such as the treatment of wrinkles on the face
• North America dominated the market with a revenue share of 42.1% owing to the easy availability of the products and the presence of a large number of skilled surgeons

Please note The report will be delivered in 3-8 business days upon order notification.